BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barbour LA, Scifres C, Valent AM, Friedman JE, Buchanan TA, Coustan D, Aagaard K, Thornburg KL, Catalano PM, Galan HL, Hay WW Jr, Frias AE, Shankar K, Simmons RA, Moses RG, Sacks DA, Loeken MR. A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes. Am J Obstet Gynecol 2018;219:367.e1-7. [PMID: 29959933 DOI: 10.1016/j.ajog.2018.06.013] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Xargay-torrent S, Mas-parés B, Carreras-badosa G, Lizárraga-mollinedo E, Tibau J, Reixach J, Platero-gutierrez E, Prats-puig A, De Zegher F, Ibáñez L, Bassols J, López-bermejo A. Metabolic programming in the offspring after gestational overfeeding in the mother: toward neonatal rescuing with metformin in a swine model. Int J Obes. [DOI: 10.1038/s41366-022-01076-5] [Reference Citation Analysis]
2 Abbott DH, Dumesic DA, Levine JE. Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy. Expert Rev Endocrinol Metab 2019;14:131-43. [PMID: 30767580 DOI: 10.1080/17446651.2019.1576522] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 12.7] [Reference Citation Analysis]
3 Blair RA, Rosenberg EA, Palermo NE. The Use of Non-insulin Agents in Gestational Diabetes: Clinical Considerations in Tailoring Therapy. Curr Diab Rep 2019;19:158. [PMID: 31811400 DOI: 10.1007/s11892-019-1243-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Dong J, Shin N, Chen S, Lei J, Burd I, Wang X. Is there a definite relationship between placental mTOR signaling and fetal growth? Biol Reprod 2020;103:471-86. [PMID: 32401303 DOI: 10.1093/biolre/ioaa070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Oskovi-Kaplan ZA, Ozgu-Erdinc AS. Management of Gestational Diabetes Mellitus. Adv Exp Med Biol 2021;1307:257-72. [PMID: 32548833 DOI: 10.1007/5584_2020_552] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Abbott DH, Rogers J, Dumesic DA, Levine JE. Naturally Occurring and Experimentally Induced Rhesus Macaque Models for Polycystic Ovary Syndrome: Translational Gateways to Clinical Application. Med Sci (Basel) 2019;7:E107. [PMID: 31783681 DOI: 10.3390/medsci7120107] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hernandez TL, Friedman JE, Barbour LA. Insulin Resistance in Pregnancy: Implications for Mother and Offspring. In: Zeitler PS, Nadeau KJ, editors. Insulin Resistance. Cham: Springer International Publishing; 2020. pp. 67-94. [DOI: 10.1007/978-3-030-25057-7_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
8 Johns EC, Denison FC, Norman JE, Reynolds RM. Gestational Diabetes Mellitus: Mechanisms, Treatment, and Complications. Trends in Endocrinology & Metabolism 2018;29:743-54. [DOI: 10.1016/j.tem.2018.09.004] [Cited by in Crossref: 108] [Cited by in F6Publishing: 110] [Article Influence: 27.0] [Reference Citation Analysis]
9 Tarry-Adkins JL, Ozanne SE, Aiken CE. Impact of metformin treatment during pregnancy on maternal outcomes: a systematic review/meta-analysis. Sci Rep 2021;11:9240. [PMID: 33927270 DOI: 10.1038/s41598-021-88650-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Valent AM, Barbour LA. Management of Women with Polycystic Ovary Syndrome During Pregnancy. Endocrinol Metab Clin North Am 2021;50:57-69. [PMID: 33518186 DOI: 10.1016/j.ecl.2020.10.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Szmuilowicz ED, Josefson JL, Metzger BE. Gestational Diabetes Mellitus. Endocrinol Metab Clin North Am 2019;48:479-93. [PMID: 31345518 DOI: 10.1016/j.ecl.2019.05.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 9.7] [Reference Citation Analysis]
12 Barbour LA. Metabolic Culprits in Obese Pregnancies and Gestational Diabetes Mellitus: Big Babies, Big Twists, Big Picture: The 2018 Norbert Freinkel Award Lecture. Diabetes Care. 2019;42:718-726. [PMID: 31010942 DOI: 10.2337/dci18-0048] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
13 Cesta CE, Cohen JM, Pazzagli L, Bateman BT, Bröms G, Einarsdóttir K, Furu K, Havard A, Heino A, Hernandez-Diaz S, Huybrechts KF, Karlstad Ø, Kieler H, Li J, Leinonen MK, Gulseth HL, Tran D, Yu Y, Zoega H, Odsbu I. Antidiabetic medication use during pregnancy: an international utilization study. BMJ Open Diabetes Res Care 2019;7:e000759. [PMID: 31798900 DOI: 10.1136/bmjdrc-2019-000759] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
14 Yang L, Lacey L, Whyte S, Quenby S, Denison FC, Dhaun N, Norman JE, Drake AJ, Reynolds RM. Metformin in obese pregnancy has no adverse effects on cardiovascular risk in early childhood. J Dev Orig Health Dis 2021;:1-5. [PMID: 34134812 DOI: 10.1017/S2040174421000301] [Reference Citation Analysis]
15 Simmons R. Metformin in pregnancy: a re-examination of its safety. J Physiol 2021. [PMID: 34762307 DOI: 10.1113/JP282324] [Reference Citation Analysis]
16 Tarry-Adkins JL, Aiken CE, Ozanne SE. Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: A systematic review and meta-analysis. PLoS Med 2019;16:e1002848. [PMID: 31386659 DOI: 10.1371/journal.pmed.1002848] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 12.3] [Reference Citation Analysis]
17 Reynolds R, Gordon A. Obesity, fertility and pregnancy: Can we intervene to improve outcomes? J Endocrinol 2018:JOE-18-0199. [PMID: 30400070 DOI: 10.1530/JOE-18-0199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Tong S, Kaitu’u-lino TJ, Hastie R, Brownfoot F, Cluver C, Hannan N. Pravastatin, proton-pump inhibitors, metformin, micronutrients, and biologics: new horizons for the prevention or treatment of preeclampsia. American Journal of Obstetrics and Gynecology 2020. [DOI: 10.1016/j.ajog.2020.09.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
19 Abbott DH. Metformin use in polycystic ovary syndrome pregnancy impacts on offspring obesity. Lancet Child Adolesc Health 2019;3:132-4. [PMID: 30704878 DOI: 10.1016/S2352-4642(19)30001-X] [Reference Citation Analysis]
20 Catalano PM. Reassessing strategies to improve pregnancy outcomes in overweight and obese women. Lancet Diabetes Endocrinol 2019;7:2-3. [PMID: 30528219 DOI: 10.1016/S2213-8587(18)30337-1] [Reference Citation Analysis]
21 Ringholm L, Damm P, Mathiesen ER. Improving pregnancy outcomes in women with diabetes mellitus: modern management. Nat Rev Endocrinol 2019;15:406-16. [PMID: 30948803 DOI: 10.1038/s41574-019-0197-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
22 Farabi SS, Hernandez TL. Low-Carbohydrate Diets for Gestational Diabetes. Nutrients 2019;11:E1737. [PMID: 31357598 DOI: 10.3390/nu11081737] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
23 Finneran MM, Landon MB. Oral Agents for the Treatment of Gestational Diabetes. Curr Diab Rep 2018;18:119. [PMID: 30267230 DOI: 10.1007/s11892-018-1093-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 3.3] [Reference Citation Analysis]
24 Alexopoulos AS, Blair R, Peters AL. Management of Preexisting Diabetes in Pregnancy: A Review. JAMA 2019;321:1811-9. [PMID: 31087027 DOI: 10.1001/jama.2019.4981] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 11.3] [Reference Citation Analysis]
25 Cluver CA, Hiscock R, Decloedt EH, Hall DR, Schell S, Mol BW, Brownfoot F, Kaitu'u-Lino TJ, Walker SP, Tong S. Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trial. BMJ 2021;374:n2103. [PMID: 34551918 DOI: 10.1136/bmj.n2103] [Reference Citation Analysis]
26 Zera CA, Seely EW. Controversies in Gestational Diabetes. touchREV Endocrinol 2021;17:102-7. [PMID: 35118455 DOI: 10.17925/EE.2021.17.2.102] [Reference Citation Analysis]
27 Hedderson MM, Badon SE, Pimentel N, Xu F, Regenstein A, Ferrara A, Neugebauer R. Association of Glyburide and Subcutaneous Insulin With Perinatal Complications Among Women With Gestational Diabetes. JAMA Netw Open 2022;5:e225026. [PMID: 35357451 DOI: 10.1001/jamanetworkopen.2022.5026] [Reference Citation Analysis]
28 Chen C, Huang Y, Dong G, Zeng Y, Zhou Z. The effect of dipeptidyl peptidase-4 inhibitor and glucagon-like peptide-1 receptor agonist in gestational diabetes mellitus: a systematic review. Gynecol Endocrinol 2020;36:375-80. [PMID: 31858859 DOI: 10.1080/09513590.2019.1703943] [Reference Citation Analysis]
29 Helal KF, Badr MS, Rafeek ME, Elnagar WM, Lashin ME. Can glyburide be advocated over subcutaneous insulin for perinatal outcomes of women with gestational diabetes? A systematic review and meta-analysis. Arch Gynecol Obstet 2020;301:19-32. [DOI: 10.1007/s00404-019-05430-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
30 Owen MD, Baker BC, Scott EM, Forbes K. Interaction between Metformin, Folate and Vitamin B12 and the Potential Impact on Fetal Growth and Long-Term Metabolic Health in Diabetic Pregnancies. Int J Mol Sci 2021;22:5759. [PMID: 34071182 DOI: 10.3390/ijms22115759] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Gonzalez CD, Alvariñas J, Bagnes MFG, Di Girolamo G. Metformin and Pregnancy Outcomes: Evidence Gaps and Unanswered Questions. Curr Clin Pharmacol 2019;14:54-60. [PMID: 30585549 DOI: 10.2174/1574884714666181224151116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Schoonejans JM, Blackmore HL, Ashmore TJ, Aiken CE, Fernandez-Twinn DS, Ozanne SE. Maternal Metformin Intervention during Obese Glucose-Intolerant Pregnancy Affects Adiposity in Young Adult Mouse Offspring in a Sex-Specific Manner. Int J Mol Sci 2021;22:8104. [PMID: 34360870 DOI: 10.3390/ijms22158104] [Reference Citation Analysis]
33 Bolte EE, Moorshead D, Aagaard KM. Maternal and early life exposures and their potential to influence development of the microbiome. Genome Med 2022;14:4. [PMID: 35016706 DOI: 10.1186/s13073-021-01005-7] [Reference Citation Analysis]
34 Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D, Das S, Kosiborod M; American Diabetes Association Professional Practice Committee., American Diabetes Association Professional Practice Committee:. 15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S232-43. [PMID: 34964864 DOI: 10.2337/dc22-S015] [Reference Citation Analysis]
35 Venkatesh KK, Chiang CW, Castillo WC, Battarbee AN, Donneyong M, Harper LM, Costantine M, Saade G, Werner EF, Boggess KA, Landon MB. Changing patterns in medication prescription for gestational diabetes during a time of guideline change in the USA: a cross-sectional study. BJOG 2021. [PMID: 34605130 DOI: 10.1111/1471-0528.16960] [Reference Citation Analysis]